Form 4: Apellis Pharmaceuticals' Chief Medical Officer Sells Shares to Cover Tax Withholding
SEC Form 4 Filing
Caroline Baumal, Chief Medical Officer of Apellis Pharmaceuticals, sold 2,816 shares of common stock on January 6, 2025, to cover tax withholding obligations.
Summary
- Caroline Baumal, the Chief Medical Officer of Apellis Pharmaceuticals, sold 2,816 shares of the company's common stock on January 6, 2025.
- The sale was executed at a price of $33.812 per share.
- The transaction was conducted to cover tax withholding obligations related to the release of Restricted Stock Units on January 3, 2025.
- Following the transaction, Baumal directly owns 55,560.37 shares of Apellis Pharmaceuticals' common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (selling shares to cover taxes). It doesn't indicate positive or negative sentiment.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes when stock options or restricted stock units vest.
Stakeholder Impact
- The sale of shares by a company executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact.
Key Dates
| Date | Description |
|---|---|
| 01/03/2025 | Restricted Stock Units released. |
| 01/06/2025 | Date of stock sale transaction. |
| 01/08/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.